24,25(OH)2D to 25(OH)D Ratio (VMR)
Ratio of 24,25-dihydroxyvitamin D to 25-hydroxyvitamin D, reflecting the enzymatic catabolic activity of 24-hydroxylase (CYP24A1).
Standard vs. Optimal Reference RangesRatio
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
0.06 - 0.14
General reference distribution across unselected commercial populations.
0.08 - 0.12
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
CYP24A1 initiates the multi-step inactivation pathway converting 25(OH)D and 1,25(OH)2D into inactive calcitroic acid.
Differential Diagnosis
Elevated Levels (VMR High)
- •Normal robust vitamin D catabolism and clearance
- •High CYP24A1 activity
Low Levels (VMR Low)
- •Idiopathic infantile hypercalcemia (CYP24A1 mutation)
- •Severe hypercalcemic nephrocalcinosis
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for VMR
- Targeted organ system imaging or functional dynamic testing related to vitamin d catabolic flux
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of 24,25(OH)2D to 25(OH)D Ratio - The New England Journal of Medicine (2021). PMID: 33990124
- [2]VMR Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate 24,25(OH)2D to 25(OH)D Ratio (VMR) into overall healthspan optimization.